PerkinElmer Stock Forecast for 2023 - 2025 - 2030
Updated on 04/23/2024
PerkinElmer Stock Forecast and Price Target
According to experts, who recently provided their 2024 price targets for PerkinElmer, the average price target is $124.88, with a high estimate of $162.00 and a low estimate of $100.00. That is a potential upside of approximately 20.66% from the last closing price of $103.50 on April, 2024. If you are not interested in PKI stock, you may be interested in its competitors.
20.66% Upside
PerkinElmer Fair Value Forecast for 2023 - 2025 - 2030
PerkinElmer's Price has decreased by 100.00% In the last five years, from $156.79 to $0.00. Next year, analysts are expecting Fair Value to reach $151.31 – an increase of 100.00%. Over the next seven years, the forecast is for Fair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| AVGO Stock Forecast | Broadcom | Outperform |
8
|
$1.25k | Buy/Sell | $1.21k | 24.08% |
| GE Stock Forecast | General Electric | Outperform |
8
|
$162.62 | Buy/Sell | $144.00 | 6.69% |
| SIE Stock Forecast | Siemens | Outperform |
10
|
175.34€ | Buy/Sell | 178.14€ | 11.50% |
| ISRG Stock Forecast | Intuitive Surgical | Outperform |
13
|
$377.08 | Buy/Sell | $408.45 | 14.03% |
| ETN Stock Forecast | Eaton | Outperform |
13
|
$312.84 | Buy/Sell | $246.22 | -0.27% |
PerkinElmer Revenue Forecast for 2023 - 2025 - 2030
In the last year, PerkinElmer's Revenue has grown from $3.78B to $3.83B – a 1.19% increase. Next year, analysts are expecting Revenue to reach $4.91B – an increase of 28.22%. Over the next seven years, the forecast is for Revenue to grow by 2.63%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| PH Stock Forecast | Parker-Hannifin Corp | Outperform |
10
|
$550.40 | Buy/Sell | $548.76 | 8.10% |
| MRK Stock Forecast | Merck KGaA | Outperform |
18
|
153.65€ | Buy/Sell | 190.06€ | 19.10% |
| BDX Stock Forecast | Becton Dickinson and Co | Outperform |
9
|
$234.36 | Buy/Sell | $284.47 | 19.47% |
.jpg)
PerkinElmer Dividend per Share Forecast for 2023 - 2025 - 2030
In the last year, PerkinElmer's Dividend per Share has decreased from $0.28 to $0.28 – a 0.00% drop! The next year, 5 experts forecast that PerkinElmer's Dividend per Share will decrease by 3.57%, reaching $0.27. In 2030, professionals predict that PerkinElmer's Dividend per Share will decrease by 0.00%, reaching $0.28.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| EMR Stock Forecast | Emerson Electric Co | Outperform |
10
|
$109.77 | Buy/Sell | $109.83 | 13.87% |
| DSY Stock Forecast | Dassault Systèmes | Outperform |
14
|
38.51€ | Buy/Sell | 45.04€ | 22.05% |
| EW Stock Forecast | Edwards Lifesciences Corp | Outperform |
11
|
$87.75 | Buy/Sell | $91.18 | 10.54% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| LONN Stock Forecast | Lonza Group | Buy |
16
|
CHF526.40 | Buy/Sell | CHF516.89 | 11.13% |
| IDXX Stock Forecast | IDEXX Laboratories | Outperform |
14
|
$493.80 | Buy/Sell | $583.92 | 21.51% |
| A Stock Forecast | Agilent Technologies | Outperform |
10
|
$139.20 | Buy/Sell | $138.82 | 8.84% |
PerkinElmer EBITDA Forecast for 2023 - 2025 - 2030
In the last year, PerkinElmer's EBITDA has grown, rising from $1.23B to $1.71B – a growth of 38.97%. For the next year, 5 analysts project PerkinElmer's EBITDA to drop by 18.09%, reaching $1.40B. By 2030, professionals believe that PerkinElmer's EBITDA will decrease by 16.08%, reaching $1.44B – a concerning trend for the company.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| RMD Stock Forecast | ResMed Inc | Outperform |
17
|
$184.22 | Buy/Sell | $201.32 | 11.28% |
| 7751 Stock Forecast | Canon | Hold |
18
|
¥4.28k | Buy/Sell | ¥3.74k | -11.24% |
| STE Stock Forecast | STERIS | Outperform |
13
|
$205.99 | Buy/Sell | $238.33 | 17.00% |
PerkinElmer EBIT Forecast for 2023 - 2025 - 2030
PerkinElmer's EBIT has grown In the last year, rising from $985.56M to $1.40B – a growth of 42.13%. According to 6 prominent analysts, PerkinElmer's EBIT will fall by 4.45% in the next year, reaching $1.34B. By 2030, professionals believe that PerkinElmer's EBIT will decrease by 2.10%, reaching $1.37B – a concerning trend for the company.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| HOLX Stock Forecast | Hologic | Outperform |
8
|
$77.19 | Buy/Sell | $81.06 | 8.82% |
| CSL Stock Forecast | Carlisle Cos Inc | Outperform |
18
|
$379.33 | Buy/Sell | $302.33 | 11.64% |
| LH Stock Forecast | Laboratory Corp of America Hol... | Outperform |
11
|
$207.97 | Buy/Sell | $241.28 | 15.40% |
PerkinElmer EPS Price Prediction Forecast for 2023 - 2025 - 2030
PerkinElmer's EPS has decreased by 100.00% In the last five years, from $8.30 to $0.00. Next year, analysts are expecting EPS to reach $8.01 – an increase of 100.00%. Over the next seven years, the forecast is for EPS to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| DGX Stock Forecast | Quest Diagnostics | Outperform |
10
|
$136.70 | Buy/Sell | $141.17 | 5.34% |
| PNR Stock Forecast | Pentair | Outperform |
11
|
$78.47 | Buy/Sell | $81.18 | 14.06% |
| ERF Stock Forecast | Eurofins Scientific | Hold |
18
|
61.60€ | Buy/Sell | 0.00€ | -4.22% |
.jpg)